Cansino Biologics Inc.’s Net Profit Dropped 98.3% in First Half of 2022

Cansino Biologics Inc. (康希诺生物股份公司) (688185.SH) reported a net profit of 16 million yuan in the first half of 2022, down 98.3% year-on-year.

Meanwhile, the company posted 629.8 million yuan in revenue, down 69.4% year-on-year.

At the end of the reporting period, it had 12 billion yuan in total assets and 3.7 billion yuan in total liabilities, with a liability-to-asset ratio of 31.1%.